The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Firodyl 62.5 mg chewable tablets for dogs

62.5 mg/tablet Chewable tablet

Ceva Santé AnimaleVPA10815/057/001

Main Information

Trade NameFirodyl 62.5 mg chewable tablets for dogs
Active SubstancesFirocoxib
Strength62.5 mg/tablet
Dosage FormChewable tablet
Licence HolderCeva Santé Animale
Licence NumberVPA10815/057/001

Group Information

ATC CodeQM01AH90 firocoxib
Therapeutic ClassN.S.A.I.D.


Licence Issued17/01/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back